Tavneos Liver Injury Update: FDA Warning and Withdrawal Proposal
The FDA warned about serious Tavneos liver injuries in 2026 and later proposed withdrawing approval. Here is what patients and families should know.
The FDA warned about serious Tavneos liver injuries in 2026 and later proposed withdrawing approval. Here is what patients and families should know.
FDA regulators are pursuing withdrawal of Tavneos approval after serious liver injury reports. Here is what patients and families should know in July 2026.